Related Experiment Video
Updated: Dec 11, 2025

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
Published on: July 26, 2017
The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle
Abhinav Adhikari1, Judith K Davie1
1Department of Biochemistry and Molecular Biology and Simmons Cancer Institute, Southern Illinois University School of Medicine , Carbondale, IL, USA.
Abstract:
The polycomb repressive complex 2 (PRC2) is an important developmental regulator responsible for the methylation of histone 3 lysine 27 (H3K27). Here, we show that the PRC2 complex regulates the cell cycle in skeletal muscle cells to control proliferation and mitotic exit. Depletions of the catalytic subunit of the PRC2 complex, EZH2, have shown that EZH2 is required for cell viability, suggesting that EZH2 promotes proliferation. We found that EZH2 directly represses both positive and negative cell cycle genes, thus enabling the PRC2 complex to tightly control the cell cycle. We show that modest inhibition or depletion of EZH2 leads to enhanced proliferation and an accumulation of cells in S phase. This effect is mediated by direct repression of cyclin D1 (Ccnd1) and cyclin E1 (Ccne1) by the PRC2 complex. Our results show that PRC2 has pleiotropic effects on proliferation as it serves to restrain cell growth, yet clearly has a function required for cell viability as well. Intriguingly, we also find that the retinoblastoma protein gene (Rb1) is a direct target of the PRC2 complex. However, modest depletion of EZH2 is not sufficient to maintain Rb1 expression, indicating that the PRC2 dependent upregulation of cyclin D1 is sufficient to inhibit Rb1 expression. Taken together, our results show that the PRC2 complex regulates skeletal muscle proliferation in a complex manner that involves the repression of Ccnd1 and Ccne1, thus restraining proliferation, and the repression of Rb1, which is required for mitotic exit and terminal differentiation.
Insights
The Polycomb Repressive Complex 2 (PRC2) controls skeletal muscle cell cycle, proliferation, and differentiation. EZH2, a key PRC2 component, represses cell cycle genes like Ccnd1 and Ccne1, and Rb1, impacting cell growth and mitotic exit.
Area of Science:
- Epigenetics and developmental biology
- Cell cycle regulation in muscle stem cells
Background:
- Polycomb Repressive Complex 2 (PRC2) is crucial for development, mediating histone 3 lysine 27 (H3K27) methylation.
- EZH2, the catalytic subunit of PRC2, is essential for cell viability and appears to promote proliferation in skeletal muscle cells.
Purpose of the Study:
- To investigate the role of the PRC2 complex in regulating the cell cycle, proliferation, and mitotic exit in skeletal muscle cells.
- To elucidate the mechanisms by which EZH2 controls cell cycle progression and differentiation.
Main Methods:
- Depletion and inhibition of EZH2 in skeletal muscle cells.
- Analysis of cell cycle gene expression, including Ccnd1, Ccne1, and Rb1.
- Assessment of cell proliferation and cell cycle phase distribution.
Main Results:
- EZH2 directly represses both positive and negative cell cycle regulators, including cyclin D1 (Ccnd1) and cyclin E1 (Ccne1).
- Modest EZH2 depletion enhances proliferation and causes S phase accumulation due to Ccnd1 and Ccne1 repression.
- The retinoblastoma protein gene (Rb1) is a direct PRC2 target, and its repression is linked to Ccnd1 upregulation, inhibiting Rb1 expression.
Conclusions:
- PRC2, via EZH2, plays a complex role in skeletal muscle proliferation by restraining growth through Ccnd1 and Ccne1 repression.
- PRC2-mediated repression of Rb1 is essential for proper mitotic exit and terminal differentiation in skeletal muscle cells.
Related Concept Videos
Negative Regulator Molecules
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

